title: [Intravesical therapy of non-muscle invasive bladder tumors].
abstract: Intravesical therapy of non-muscle invasive bladder tumors has a long tradition. With regard to low grade tumors prevention of tumor recurrence remains the main endpoint, whereas in high grade tumors prevention of tumor progression is the main aim of intravesical treatment. The following article critically discusses these aspects of non-muscle invasive bladder tumors.
authors.affiliation: Klinik und Poliklinik für Urologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122 Essen, Deutschland. Frank.vomDorp@uk-essen.de
authors.forename: F
authors.initials: F
authors.lastname: Vom Dorp
authors.forename: S
authors.initials: S
authors.lastname: Tschirdewahn
authors.forename: G
authors.initials: G
authors.lastname: Lümmen
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D015653:Cystectomy; D003558:Cystoscopy; D018450:Disease Progression; D006801:Humans; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000517:prevention & control; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D001500:BCG Vaccine